Pharmaco-phosphoproteomic analysis of cancer-associated KIT mutations D816V and V560G

- Murray, Heather C., Miller, Kasey, Dun, Matthew D., Verrills, Nicole M.

Phosphoproteomic analysis of the adaption of epididymal epithelial cells to corticosterone challenge

- Skerrett-Byrne, David A., Stanger, Simone J., Dun, Matthew D., Pang, Terence Y., Nixon, Brett, Trigg, Natalie A., Anderson, Amanda L., Sipilä, Petra, Bernstein, Ilana R., Lord, Tessa, Schjenken, John E., Murray, Heather C., Verrills, Nicole M.

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma

- Duchatel, Ryan J., Jackson, Evangeline R., Kearney, Padraic S., Jamaluddin, M. Fairuz B., Douglas, Alicia M., Beitaki, Tyrone, McEwen, Holly P., Persson, Mika L., Hocke, Emily A., Jain, Vaibhav, Aksu, Michael, Manning, Elizabeth E., Parackal, Sarah G., Murray, Heather C., Verrills, Nicole M., Hua, Susan, Cairns, Murray J., Alvaro, Frank, Dayas, Christopher V., Dun, Matthew D., Hua, S, de Bock, CE, Colino-Sanguino, Y, Kiltschewskij, Dylan, Valdes-Mora, F, Tsoli, M, Ziegler, DS, Cairns, MJ, Raabe, EH, Vitanza, NA, Hulleman, E, Phoenix, TN, Koschmann, C, Alvaro, F, Findlay, Izac J., Dayas, CV, Tinkle, CL, Wheeler, H, Whittle, JR, Eisenstat, DD, Firestein, R, Mueller, S, Valvi, S, Hansford, JR, Ashley, DM, Mannan, Abdul, Gregory, SG, Kilburn, LB, Nazarian, J, Cain, JE, Dun, MD, Staudt, Dilana E., Thomas, Bryce C., Germon, Zacary P., Laternser, Sandra

Proteomic and phosphoproteomic characterisation of primary mouse embryonic fibroblasts

- Chen, Yanfang, Roselli, Severine, Panicker, Nikita, Brzozowski, Joshua S., Skerrett-Byrne, David A., Murray, Heather C., Verrills, Nicole M.

The impact of a regionally based translational cancer research collaborative in Australia using the FAIT methodology

- Paul, Christine L., Verrills, Nicole M., Ackland, Stephen, Scott, Rodney, Goode, Susan, Thomas, Ann, Lukeman, Sarah, Nielsen, Sarah, Weidenhofer, Judith, Lynam, James, Fradgley, Elizabeth A., Martin, Jarad, Greer, Peter, Smith, Stephen, Griffin, Cassandra, Avery-Kiejda, Kelly A., Zdenkowski, Nick, Searles, Andrew, Ramanathan, Shanthi

Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies

- Germon, Zacary P., Sillar, Jonathan R., McLachlan, Tabitha, Schjenken, John E., Skerrett-Byrne, David A., Huang, Honggang, Melo-Braga, Marcella N., Plank, Maximillan W., Alvaro, Frank, Chamberlain, Janis, De Iuliis, Geoff, Aitken, R. John, Mannan, Abdul, Nixon, Brett, Wei, AH, Enjeti, Anoop K., Huang, Y, Lock, RB, Larsen, MR, Lee, Heather, Vaghjiani, V, Cain, JE, de Bock, CE, Duchatel, Ryan J., Verrills, Nicole M., Dun, Matthew D., Staudt, Dilana, Murray, Heather C., Findlay, Izac J., Jackson, Evangeline R., McEwen, Holly P., Douglas, Alicia M.

Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia

- Murray, Heather C., Miller, Kasey, Brzozowski, Joshua S., Kahl, Richard G. S., Smith, Nathan D., Humphrey, Sean J., Dun, Matthew D., Verrills, Nicole M.

Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells

- Tiburcius, Steffi, Krishnan, Kannan, Vinu, Ajayan, Jose, Linta, Patel, Vaishwik, Ghosh, Arnab, Sathish, C. I., Weidenhofer, Judith, Yang, Jae-Hun, Verrills, Nicole M., Karakoti, Ajay

Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection

- Staudt, Dilana E., Murray, Heather C., Findlay, Izac J., Kearney, Padraic S., Mannan, Abdul, McEwen, Holly P., Douglas, Alicia M., Nixon, Brett, Verrills, Nicole M., Dun, Matthew D., Skerrett-Byrne, David A., Smith, Nathan D., Jamaluddin, M. Fairuz B., Kahl, Richard G. S., Duchatel, Ryan J., Germon, Zacary P., McLachlan, Tabitha, Jackson, Evangeline R.

Role of the prorenin receptor in endometrial cancer cell growth

- Martin, Jacinta H., Mohammed, Riazuddin, Lumbers, Eugenie R., Pringle, Kirsty G., Delforce, Sarah J., Skerrett-Byrne, David A., de Meaultsart, Celine Corbisier, Almazi, Juhura G., Stephens, Andrew N., Verrills, Nicole M., Dimitriadis, Evdokia, Wang, Yu

scTEM-seq: Single-cell analysis of transposable element methylation to link global epigenetic heterogeneity with transcriptional programs

- Hunt, Kooper V., Burnard, Sean M., Roper, Ellise A., Bond, Danielle R., Dun, Matthew D., Verrills, Nicole M., Enjeti, Anoop K., Lee, Heather J.

Triple Surfactant Assisted Synthesis of Novel Core-Shell Mesoporous Silica Nanoparticles with High Surface Area for Drug Delivery for Prostate Cancer

- Tiburcius, Steffi, Krishnan, Kannan, Patel, Vaishwik, Netherton, Jacob, Sathish, C. I., Weidenhofer, Judith, Yang, Jae-Hun, Verrills, Nicole M., Karakoti, Ajay, Vinu, Ajayan

Silica-based nanomaterials as drug delivery tools for skin cancer (melanoma) treatment

- Trinh, Hoang Trung, Mohanan, Shan, Radhakrishnan, Deepika, Tiburcius, Steffi, Yang, Jae-Hun, Verrills, Nicole M., Karakoti, Ajay, Vinu, Ajayan

Silica-Based Nanoparticles as Drug Delivery Vehicles for Prostate Cancer Treatment

- Tiburcius, Steffi, Krishnan, Kannan, Yang, Jae-Hun, Hashemi, Fatemeh, Singh, Gurwinder, Radhakrishnan, Deepika, Trinh, Hoang Trung, Verrills, Nicole M., Karakoti, Ajay, Vinu, Ajayan

Ppp2r2aKnockout Mice Reveal That Protein Phosphatase 2A Regulatory Subunit, PP2A-B55 alpha, Is an Essential Regulator of Neuronal and Epidermal Embryonic Development

- Panicker, Nikita, Coutman, Melody, Lawlor-O'Neill, Charley, Kahl, Richard G. S., Roselli, Severine, Verrills, Nicole M.

Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia

- Dun, Matthew D., Mannan, Abdul, Germon, Zacary, Faulkner, Sam, Chi, Mengna, Skerrett-Byrne, David, Murray, Heather C., Flanagan, Hayley, Almazi, Juhura G., Hondermarck, Hubert, Nixon, Brett, De Iuliis, Geoff, Rigby, Callum J., Chamberlain, J, Alvaro, F, de Bock, CE, Morris, JC, Enjeti, Anoop K., Verrills, Nicole M., Butler, Stephen, Toop, Hamish D., Beck, Dominik, Connerty, Patrick, Sillar, Jonathan, Kahl, Richard G. S., Duchatel, Ryan J.

Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia"

- Perrotti, Danilo, Agarwal, Anupriya, Lucas, Claire M., Narla, Goutham, Neviani, Paolo, Odero, Maria D., Ruvolo, Peter P., Verrills, Nicole M.

Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer

- Nader, Cassandra P., Cidem, Aylin, Verrills, Nicole M., Ammit, Alaina J.

Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal Cancer

- Almazi, Juhura G., Pockney, Peter, Gedye, Craig, Smith, Nathan D., Hondermarck, Hubert, Verrills, Nicole M., Dun, Matthew D.

Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance

- Staudt, Dilana, Murray, Heather C., McLachlan, Tabitha, Alvaro, Frank, Enjeti, Anoop K., Verrills, Nicole M., Dun, Matthew D.